Imunon, Inc.CLSN

NASDAQHealthcareBiotechnology$1.95-0.68%

A clinical-stage biotechnology company developing DNA-based immunotherapies aimed at treating difficult cancers, including ovarian cancer. Its lead candidate, IMNN-001, uses a nanoparticle delivery platform designed to stimulate the body’s immune response against tumors. Investors track the micro-ca...

Market Cap: $14.5M

This page tracks all publicly disclosed congressional trades in Imunon, Inc. (CLSN), a company in the Healthcare sector. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.

Total Disclosures

Unique Politicians

Buys

Sells

Congressional Trading History

No congressional trades found for this stock.

All stocks traded by Congress Full trade feed Most active traders About the STOCK Act Report missing trade

Imunon, Inc.CLSN

Congressional Trading History

Related